Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
6
|
pubmed:dateCreated |
1993-7-9
|
pubmed:abstractText |
The uptake, distribution, and clearance properties of 123I-IMP in the brain were evaluated in controls and asymptomatic crack users to investigate cerebral blood flow alterations in crack abuse. Serial dynamic planar images of the brain (0-25 min), SPECT of the brain (0.5 hr and 4 hr) and whole-body scans (75 min) were obtained in 21 crack abusers and 21 control subjects. Major observations include: (a) foci of abnormally reduced 123I-IMP activity mainly in the frontal and parieto-occipital cortex or marked irregularities in the uptake of 123I-IMP throughout the cerebral cortex consistent with moderate to severe disruption in regional cerebral blood flow were observed on the 0.5 hr SPECT images of 16/21 asymptomatic crack users; (b) no correlation could be demonstrated between the incidence or severity of SPECT perfusion abnormality with the frequency, amount or length of time of crack use; (c) focal perfusion defects observed in 6/21 crack users on the 0.5-hr SPECT images partially or completely filled-in on delayed SPECT at 4 hr in four of six subjects; (d) the rate of cerebral uptake of 123I-IMP in crack users averaged 23% less than observed in control subjects over the first 25 min after tracer administration; and (e) 123I-IMP activity reaching the brain of cigarette smoking control subjects (n = 14) at 25 min after injection averaged 42.5% less than in nonsmoking controls (n = 7). Quantitative measurements of the uptake and distribution properties of 123I-IMP in the brain proved to be an objective, sensitive and useful measure of regional cerebral blood flow in crack abuse.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Jun
|
pubmed:issn |
0161-5505
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
34
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
899-907
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:8509856-Adult,
pubmed-meshheading:8509856-Amphetamines,
pubmed-meshheading:8509856-Brain,
pubmed-meshheading:8509856-Cerebrovascular Circulation,
pubmed-meshheading:8509856-Crack Cocaine,
pubmed-meshheading:8509856-Female,
pubmed-meshheading:8509856-Humans,
pubmed-meshheading:8509856-Image Processing, Computer-Assisted,
pubmed-meshheading:8509856-Iodine Radioisotopes,
pubmed-meshheading:8509856-Iofetamine,
pubmed-meshheading:8509856-Male,
pubmed-meshheading:8509856-Smoking,
pubmed-meshheading:8509856-Substance-Related Disorders,
pubmed-meshheading:8509856-Tomography, Emission-Computed, Single-Photon
|
pubmed:year |
1993
|
pubmed:articleTitle |
SPECT and planar brain imaging in crack abuse: iodine-123-iodoamphetamine uptake and localization.
|
pubmed:affiliation |
Medical Department, Brookhaven National Laboratory, Upton, New York.
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, Non-P.H.S.
|